1.Two Cases of Generalized Pustular Psoriasis: Successful Treatment with Infliximab.
Hoon Soo KIM ; Hyang Suk YOU ; Hyun Ho CHO ; Won Jeong KIM ; Je Ho MUN ; Margaret SONG ; Hyun Chang KO ; Moon Bum KIM ; Byung Soo KIM
Annals of Dermatology 2014;26(6):787-788
No abstract available.
Psoriasis*
;
Infliximab
2.Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment.
Eun Sun KIM ; Yoon Tae JEEN ; Bora KEUM ; Yeon Seok SEO ; Hoon Jai CHUN ; Soon Ho UM ; Chang Duck KIM ; Ho Sang RYU
Gut and Liver 2009;3(4):325-328
Cap polyposis is a rare disorder with characteristic endoscopic and histological features; its etiology is still unknown, and no specific treatment has been established. We report a case of cap polyposis that improved remarkably after infliximab infusion and had no recurrence for 3 years.
Antibodies, Monoclonal
;
Recurrence
;
Infliximab
3.Successful Treatment of Tolosa-Hunt Syndrome after a Single Infusion of Infliximab
Journal of Clinical Neurology 2018;14(1):126-127
No abstract available.
Infliximab
;
Tolosa-Hunt Syndrome
4.Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
Annals of Coloproctology 2019;35(5):225-226
No abstract available.
Crohn Disease
;
Fistula
;
Infliximab
5.A Type II Segmental Vitiligo Developed under Infliximab Treatment for Ulcerative Colitis.
Tae Hyung RYU ; Dong Won LEE ; Jae Eun CHOI ; Hyo Hyun AHN ; Young Chul KYE ; Soo Hong SEO
Annals of Dermatology 2017;29(6):826-827
No abstract available.
Colitis, Ulcerative*
;
Infliximab*
;
Ulcer*
;
Vitiligo*
6.Remission of Refractory Intestinal Behcet's Disease with Infliximab.
Woo Young CHOI ; Jung Yoon CHOE ; Joo Hyoung LEE ; Chang Jin SEO ; Keun Woo PARK ; Ji Young KIM ; Sung Hoon PARK ; Jin Hyang SHIN
The Journal of the Korean Rheumatism Association 2007;14(1):61-65
Behcet's disease is a chronic, relapsing vasculitis of unknown origin that affects nearly all organs. The most frequent extra-oral sites of gastrointestinal involvement are the ileocecal lesion and the colon. The lesions are typically resistant to medical treatment and frequently recur with surgical treatment. We describe a patient who had intestinal Behcet's disease complicated perforation and enterocutanous fistula with a good response to infliximab.
Colon
;
Fistula
;
Humans
;
Infliximab
;
Vasculitis
7.Symptomless Pulmonary Cryptococcosis in a Psoriatic Arthritis Patient during Infliximab Therapy.
Saori YAMADA ; Ikko KAJIHARA ; Takamitsu JOHNO ; Satoshi FUKUSHIMA ; Masatoshi JINNIN ; Aiko MASUNAGA ; Hirotsugu KOHROGI ; Hironobu IHN
Annals of Dermatology 2016;28(2):269-270
No abstract available.
Arthritis, Psoriatic*
;
Cryptococcosis*
;
Humans
;
Infliximab
8.Symptomless Pulmonary Cryptococcosis in a Psoriatic Arthritis Patient during Infliximab Therapy.
Saori YAMADA ; Ikko KAJIHARA ; Takamitsu JOHNO ; Satoshi FUKUSHIMA ; Masatoshi JINNIN ; Aiko MASUNAGA ; Hirotsugu KOHROGI ; Hironobu IHN
Annals of Dermatology 2016;28(2):269-270
No abstract available.
Arthritis, Psoriatic*
;
Cryptococcosis*
;
Humans
;
Infliximab
9.Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?.
Intestinal Research 2017;15(2):147-148
No abstract available.
Adalimumab*
;
Crohn Disease*
;
Fistula*
;
Infliximab*
10.Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
Korean Circulation Journal 2019;49(2):192-193
No abstract available.
Infliximab
;
Mucocutaneous Lymph Node Syndrome
Result Analysis
Print
Save
E-mail